Table 4.

NMR Data for Veraguamide F (6) in CDCl₃

unit	C/H no.	δCa	δ (J in Hz)b
Hmoya	1	170.9, C
	2	42.2, CH	3.24 br q (7.3)
	3	76.6, CH	4.89, dt (10.6, 2.4)
	4a	27.5, CH2	2.08, m
	4b		1.64, m
	5a	25.2, CH2	1.65, m
	5b		1.45, m
	6	18.0, CH2	2.20, m
	7	83.5, C
	8	68.9, CH	1.93, t (2.5)
	9	14.6, CH3	1.29, d (7.3)
N-Me-Val-1	1	170.7, C
	2	65.3, CH	3.95, d (10.4)
	3	28.3, CH	2.32, m
	4	19.6, CH3	1.00, d (6.5)
	5	19.7, CH3	0.93, d (6.5)
	N-Me	28.7, CH3	3.06, s
Pro	1	172.3, C
	2	57.1, CH	4.97, dd (9.0, 4.5)
	3a	29.1, CH2	2.27, m
	3b		1.83, m
	4a	25.0, CH2	2.07, m
	4b		1.97, m
	5a	47.0, CH2	3.62, m
	5b		3.56, m
Pla	1	165.4, C
	2	72.8, CH	5.47, dd (9.8, 4.0)
	3	36.7, CH2	3.17, m
			2.91, m
	4	136.2, C
	5//9	129.3, CH	7.18, d (8.0)
	6/8	128.5, CH	7.28, m
	7	126.7, CH	7.20, m
N-Me-Val-2	1	168.9, C
	2	65.8, CH	4.05, d (10.5)
	3	27.4, CH	2.08, m
	4	19.8, CH3	0.89, d (6.8)
	5	20.0, CH3	0.91, d (6.8)
	N-Me	29.0, CH3	2.60, s
Val	1	173.4, C
	2	52.7, CH	4.76, dd (8.5, 6.1)
	3	32.3, CH	1.98, m
	4	20.3, CH3	0.91, d (6.6)
	5	17.7, CH3	0.88, d (6.6)
	NH		6.28, d (8.5)

^a100 MHz

^b600 MHz